Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis.

Zanotti L, Romani C, Tassone L, Todeschini P, Tassi RA, Bandiera E, Damia G, Ricci F, Ardighieri L, Calza S, Marchini S, Beltrame L, Tognon G, D'Incalci M, Pecorelli S, Sartori E, Odicino F, Ravaggi A, Bignotti E.

BMC Cancer. 2017 May 25;17(1):366. doi: 10.1186/s12885-017-3334-1.

2.

The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate.

Boylan KL, Buchanan PC, Manion RD, Shukla DM, Braumberger K, Bruggemeyer C, Skubitz AP.

Oncotarget. 2017 Feb 7;8(6):9717-9738. doi: 10.18632/oncotarget.14206.

3.

Claudin-4 activity in ovarian tumor cell apoptosis resistance and migration.

Hicks DA, Galimanis CE, Webb PG, Spillman MA, Behbakht K, Neville MC, Baumgartner HK.

BMC Cancer. 2016 Oct 11;16(1):788.

4.

Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.

Iwanicki MP, Chen HY, Iavarone C, Zervantonakis IK, Muranen T, Novak M, Ince TA, Drapkin R, Brugge JS.

JCI Insight. 2016 Jul 7;1(10). pii: e86829.

5.

Challenges of Pancreatic Cancer.

Dimastromatteo J, Houghton JL, Lewis JS, Kelly KA.

Cancer J. 2015 May-Jun;21(3):188-93. doi: 10.1097/PPO.0000000000000109. Review.

6.

Emerging roles of claudins in human cancer.

Kwon MJ.

Int J Mol Sci. 2013 Sep 4;14(9):18148-80. doi: 10.3390/ijms140918148. Review.

7.

Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy.

English DP, Santin AD.

Int J Mol Sci. 2013 May 17;14(5):10412-37. doi: 10.3390/ijms140510412. Review.

8.

Claudin-6: a novel receptor for CPE-mediated cytotoxicity in ovarian cancer.

Lal-Nag M, Battis M, Santin AD, Morin PJ.

Oncogenesis. 2012 Nov 12;1:e33. doi: 10.1038/oncsis.2012.32.

9.

Claudins play a role in normal and tumor cell motility.

Webb PG, Spillman MA, Baumgartner HK.

BMC Cell Biol. 2013 Mar 23;14:19. doi: 10.1186/1471-2121-14-19.

10.

Establishment, characterization and downstream application of primary ovarian cancer cells derived from solid tumors.

Sueblinvong T, Ghebre R, Iizuka Y, Pambuccian SE, Isaksson Vogel R, Skubitz AP, Bazzaro M.

PLoS One. 2012;7(11):e50519. doi: 10.1371/journal.pone.0050519. Epub 2012 Nov 30.

11.

Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.

Shang X, Lin X, Alvarez E, Manorek G, Howell SB.

Neoplasia. 2012 Oct;14(10):974-85.

12.

Epithelial-mesenchymal transition in ovarian carcinoma.

Davidson B, Tropé CG, Reich R.

Front Oncol. 2012 Apr 10;2:33. doi: 10.3389/fonc.2012.00033. eCollection 2012.

Supplemental Content

Support Center